MeCRU Research Unit (MeCRU), at SMU has been officially launched as the research site for Phase III Paediatric COVID-19 Vaccine study conducted by the Numolux Group and Sinovac on 10 September 2021. The very first child and the second one had the honor to receive their jabs which kick started the study.
Botswana delegation benchmarks SMU dentistry excellence
Sefako Makgatho Health Sciences University (SMU) has strengthened its position as a continental leader in health sciences education following a landmark clinical benchmarking session with Botswana’s private institution, Boitekanelo College. Hosted at SMU and...
